34
NPS Score
VS
Adaptive Biotechnologies Claimed Company
- EMPLOYEE
PARTICIPANTS - 27
- TOTAL
RATINGS
Juno Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 6
- TOTAL
RATINGS
Adaptive Biotechnologies vs Juno Therapeutics
Compare Adaptive Biotechnologies versus Juno Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 27 employees and customers of Adaptive Biotechnologies and 6 employees and customers of Juno Therapeutics.
Adaptive Biotechnologies
Adaptive Biotechnologies's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Adaptive Biotechnologies. Their current valuation is $5.69B.
Juno Therapeutics
Juno Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Juno Therapeutics.
4/5
Product Quality
2.7/5
3.7/5
Pricing
2.7/5
3.7/5
Customer Service
2.7/5
| 67% | Promoters |
|---|---|
| 0% | Passive |
| 33% | Detractors |
Net Promoter Score
Winner by 20
14
NPS Score
| 57% | Promoters |
|---|---|
| 0% | Passive |
| 43% | Detractors |
See how Adaptive Biotechnologies compares to its competitors
See how Juno Therapeutics compares to its competitors
Working at Adaptive Biotechnologies vs Working at Juno Therapeutics
74 / 100
CEO Rating
86 / 100
CEO Rating
Winner by 12%
Adaptive Biotechnologies
Adaptive Biotechnologies doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Juno Therapeutics
Employees at Juno Therapeutics rate their CEO, Hans Bishop, 86/100. This score is 12% higher than the scores of Adaptive Biotechnologies' CEO, Chad Robins.